The Translational Genomics Research Institute, is a nonprofit medical research institute dedicated to conducting groundbreaking research with life-changing results. The Arizona-based institute works to unravel the genetic components of common and complex diseases, including cancer, neurological disorders, infectious disease and rare childhood disorders. By identifying treatment options, TGen helps make medicine more rational, more precise and more personal. With its most recent upgrade, this supercomputer, based on Dell EMC PowerEdge servers, offers the processing power of 3,000 Intel® Xeon® compute cores. The cluster delivers 1 million CPU hours per month and performs 50 trillion operations per second, according to TGen. The genomics sequencing system also offers more than 3 petabytes of Dell EMC Isilon scale-out network-attached storage. As part of its humanitarian mission, TGen works to unravel the secrets of infectious diseases. That’s the case today as the institute participates actively in the global fight against the deadly COVID-19 disease. When we talk about genome sequencing, we’re talking about sequencing any living organism,” James Lowey, TGen’s chief information officer explains. “This planet uses DNA to encode how life exists. Viruses are no different in that respect. Although they can be much simpler from a genetic standpoint than a human, they still require DNA as the code that makes them tick. It’s important to understand how that works in order to fight the disease. James Lowey, CIO at TGen Mike McManus, Director, Precision Medicine & Principal Engineer at Intel Corporation